Equity Overview
Price & Market Data
Price: $1.30
Daily Change: -$0.06 / 4.62%
Range: $1.26 - $1.36
Market Cap: $47,543,860
Volume: 138,375
Performance Metrics
1 Week: -6.47%
1 Month: 23.81%
3 Months: 31.87%
6 Months: -5.11%
1 Year: 23.81%
YTD: 0.78%
Company Details
Employees: 10
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.